NCT06004583 is a clinical trial of Biochemical blood analysis in Acne Vulgaris, sponsored by Ataturk University.

Who is sponsoring NCT06004583?

NCT06004583 is sponsored by Ataturk University.

What drugs are being tested in NCT06004583?

Interventions in NCT06004583: Biochemical blood analysis.

What condition does NCT06004583 study?

NCT06004583 studies Acne Vulgaris.

Is NCT06004583 still recruiting?

NCT06004583 is currently completed. Last updated 22 August 2023.

Last reviewed 2023-08-22 · How we verify

NCT06004583

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

C-Reactive Protein/Albumin Ratio and Acne Vulgaris

Completed Last updated 22 August 2023

What this trial tests

trial testing Biochemical blood analysis in Acne Vulgaris in 96 participants. Completed in 1 May 2023.

Timeline

5 January 2022

Primary endpoint
2 February 2023

1 May 2023

Quick facts

Lead sponsor	Ataturk University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	96
Start date	5 January 2022
Primary completion	2 February 2023
Estimated completion	1 May 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Biochemical blood analysis

Conditions studied

Acne Vulgaris — all drugs for Acne Vulgaris →

Sponsor

Ataturk University

Who can join

Adults 18 to 40, any sex, with Acne Vulgaris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Acne vulgaris, an inflammatory disease, was investigated in this study with the claim that C-reactive protein (CRP) / albumin ratio and some hematological parameter ratios have the potential to be used as inflammatory markers to monitor disease severity and prognosis. Methods: A descriptive cross-sectional study was conducted with two groups of patients aged 18-65 years, 61 patients diagnosed with acne vulgaris and 35 healthy control patients, and routine hemogram and biochemical parameters were compared. The Global Acne Severity Index was used to determine the severity of acne vulgaris.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Relationships Between Disease Severity and the C-reactive Protein/Albumin Ratio and Various Hematological Parameters in Patients With Acne Vulgaris.
Pala E, Bayraktar M. · · 2023 · cited 2× · PMID 37750127 · DOI 10.7759/cureus.44089

Verify or expand the search:

Other recruiting trials for Acne Vulgaris

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07474883 — Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris · EARLY_PHASE1 · recruiting
NCT07186413 — A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne · Phase 3 · recruiting
NCT07056673 — Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study · NA · recruiting
NCT07102186 — Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris · Phase 4 · recruiting

Other Ataturk University trials

Trials by the same sponsor.

NCT07518537 — Bulk-Fill Composite Restorations: Clinical Evaluation · NA · not yet recruiting
NCT07241156 — Creative Drama on Gender Role Stress, Attitudes Toward Violence Against Women, and Aggression · NA · not yet recruiting
NCT07451418 — The Effect of Mindfulness Compassionate Living Training on Unwanted Pregnancies · NA · not yet recruiting
NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
NCT07375277 — Effects Of Biceps Transposition Without Tenotomy For Augmentation Of Massive Rotator Cuff Repairs · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06004583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ataturk University
Last refreshed: 22 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06004583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing